AVE Science&Technology CO.,LTD (SHA:688067)
China · Delayed Price · Currency is CNY 21.45
+0.30 (1.42%)
Aug 4, 2026, 3:00 PM CST
SHA:688067 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 214.58 | 214.84 | 198.73 | 196.87 | 192.45 | 206.03 |
Other Revenue | 4.84 | 4.84 | 4.59 | 3.44 | 4.33 | 4.63 |
| 219.42 | 219.67 | 203.32 | 200.31 | 196.77 | 210.67 | |
Revenue Growth | 4.59% | 8.04% | 1.50% | 1.80% | -6.59% | 16.91% |
Cost of Revenue | 85.8 | 87.1 | 82.56 | 87.5 | 91.17 | 86.85 |
Gross Profit | 133.62 | 132.57 | 120.76 | 112.81 | 105.61 | 123.82 |
Selling, General & Admin | 83.57 | 83.96 | 82.74 | 74.48 | 69.84 | 68.93 |
Research & Development | 27.14 | 27.35 | 25.38 | 27.72 | 33.08 | 31.2 |
Other Operating Expenses | -2.84 | -2.41 | -2.77 | -2.05 | -2 | -1.77 |
Operating Expenses | 108.47 | 109.59 | 105.99 | 100.98 | 101.5 | 99.09 |
Operating Income | 25.16 | 22.98 | 14.77 | 11.83 | 4.1 | 24.73 |
Interest Expense | -0.37 | -0.2 | - | - | - | - |
Interest & Investment Income | 5.7 | 5.9 | 7.23 | 6.39 | 6.52 | 3.1 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.17 | 0 | 0 | -0.01 |
Other Non Operating Income (Expenses) | -0.16 | -0.04 | -0.25 | -0.41 | -0.1 | -0.02 |
EBT Excluding Unusual Items | 30.33 | 28.67 | 21.92 | 17.81 | 10.53 | 27.79 |
Gain (Loss) on Sale of Investments | 0.35 | 0.35 | 0.05 | 0.01 | - | - |
Gain (Loss) on Sale of Assets | -0.12 | -0.11 | -0.03 | -0.01 | -0.2 | -0.01 |
Asset Writedown | 0.03 | - | - | - | - | - |
Other Unusual Items | 1.03 | 1.03 | 1.6 | 4.55 | 7.87 | 6.13 |
Pretax Income | 31.62 | 29.94 | 23.53 | 22.36 | 18.2 | 33.91 |
Income Tax Expense | 1.65 | 1.07 | 0.69 | 0.83 | 0.23 | 2.64 |
Net Income | 29.97 | 28.87 | 22.84 | 21.53 | 17.97 | 31.28 |
Net Income to Common | 29.97 | 28.87 | 22.84 | 21.53 | 17.97 | 31.28 |
Net Income Growth | 24.41% | 26.38% | 6.07% | 19.81% | -42.53% | 3.90% |
Shares Outstanding (Basic) | 66 | 67 | 67 | 67 | 69 | 59 |
Shares Outstanding (Diluted) | 66 | 67 | 67 | 67 | 69 | 59 |
Shares Change | -0.26% | -0.07% | -0.17% | -2.65% | 17.15% | 15.67% |
EPS (Basic) | 0.45 | 0.43 | 0.34 | 0.32 | 0.26 | 0.53 |
EPS (Diluted) | 0.45 | 0.43 | 0.34 | 0.32 | 0.26 | 0.53 |
EPS Growth | 24.74% | 26.47% | 6.25% | 23.08% | -50.94% | -10.17% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 36.21 | 38.32 | 18.66 | 18.23 | 8.54 | 26.67 |
Free Cash Flow Per Share | 0.55 | 0.57 | 0.28 | 0.27 | 0.12 | 0.45 |
Dividend Per Share | 0.154 | 0.154 | 0.100 | 0.100 | 0.100 | 0.300 |
Dividend Growth | 54.00% | 54.00% | 0% | 0% | -66.67% | - |
Gross Margin | 60.90% | 60.35% | 59.39% | 56.32% | 53.67% | 58.77% |
Operating Margin | 11.47% | 10.46% | 7.27% | 5.91% | 2.09% | 11.74% |
Profit Margin | 13.66% | 13.14% | 11.23% | 10.75% | 9.13% | 14.85% |
Free Cash Flow Margin | 16.50% | 17.45% | 9.18% | 9.10% | 4.34% | 12.66% |
EBITDA | 36.36 | 34.25 | 26.29 | 22.68 | 13.14 | 31.47 |
EBITDA Margin | 16.57% | 15.59% | 12.93% | 11.32% | 6.68% | 14.94% |
D&A For EBITDA | 11.2 | 11.27 | 11.52 | 10.85 | 9.03 | 6.75 |
EBIT | 25.16 | 22.98 | 14.77 | 11.83 | 4.1 | 24.73 |
EBIT Margin | 11.47% | 10.46% | 7.27% | 5.91% | 2.09% | 11.74% |
Effective Tax Rate | 5.22% | 3.58% | 2.93% | 3.69% | 1.24% | 7.77% |
Revenue as Reported | 219.42 | 219.67 | 203.32 | 200.31 | 196.77 | 210.67 |
Advertising Expenses | - | 1.62 | 1.62 | 1.05 | 0.68 | 1.6 |